Profile | GDS5420 / 203491_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 516.03 | 68 |
GSM1296119 | B_lesional_pre-dose | 892.99 | 77 |
GSM1296076 | C_lesional_pre-dose | 452.19 | 67 |
GSM1296092 | D_lesional_pre-dose | 440.7 | 66 |
GSM1296103 | E_lesional_pre-dose | 881.97 | 77 |
GSM1296078 | F_lesional_pre-dose | 450.81 | 67 |
GSM1296107 | G_lesional_pre-dose | 866.07 | 77 |
GSM1296109 | H_lesional_pre-dose | 1315.28 | 84 |
GSM1296080 | I_lesional_pre-dose | 433.34 | 66 |
GSM1296090 | J_lesional_pre-dose | 502.59 | 68 |
GSM1296074 | K_lesional_pre-dose | 550.91 | 70 |
GSM1296111 | L_lesional_pre-dose | 1131.36 | 81 |
GSM1296099 | M_lesional_pre-dose | 558.7 | 69 |
GSM1296086 | O_lesional_pre-dose | 428.68 | 66 |
GSM1296117 | P_lesional_pre-dose | 1117.79 | 81 |
GSM1296113 | Q_lesional_pre-dose | 1168.93 | 82 |
GSM1296096 | R_lesional_pre-dose | 588.96 | 70 |
GSM1296105 | S_lesional_pre-dose | 406.79 | 64 |
GSM1296098 | T_lesional_pre-dose | 666.66 | 72 |
GSM1296101 | U_lesional_pre-dose | 660.6 | 72 |
GSM1296121 | V_lesional_pre-dose | 986.73 | 79 |
GSM1296088 | W_lesional_pre-dose | 336.18 | 61 |
GSM1296082 | X_lesional_pre-dose | 587.87 | 71 |
GSM1296115 | Y_lesional_pre-dose | 939.84 | 78 |
GSM1296084 | Z_lesional_pre-dose | 573.66 | 70 |
GSM1296072 | B_lesional_day8 | 813.32 | 76 |
GSM1296069 | L_lesional_day8 | 1113.06 | 81 |
GSM1296071 | P_lesional_day8 | 1013.33 | 80 |
GSM1296070 | Y_lesional_day8 | 1009.6 | 80 |
GSM1296073 | V_lesional_day8 | 772.72 | 75 |
GSM1296034 | A_lesional_day15 | 470.41 | 66 |
GSM1296041 | G_lesional_day15 | 900.24 | 78 |
GSM1296035 | R_lesional_day15 | 581.41 | 70 |
GSM1296038 | U_lesional_day15 | 508.69 | 68 |
GSM1296047 | B_lesional_day15 | 793.92 | 75 |
GSM1296039 | E_lesional_day15 | 714.4 | 74 |
GSM1296042 | H_lesional_day15 | 834.09 | 76 |
GSM1296043 | L_lesional_day15 | 967.45 | 79 |
GSM1296037 | M_lesional_day15 | 489.57 | 67 |
GSM1296046 | P_lesional_day15 | 1097.27 | 81 |
GSM1296044 | Q_lesional_day15 | 924.15 | 78 |
GSM1296045 | Y_lesional_day15 | 1015.23 | 80 |
GSM1296025 | C_lesional_day15 | 555.9 | 69 |
GSM1296033 | D_lesional_day15 | 353.29 | 62 |
GSM1296027 | I_lesional_day15 | 242.4 | 57 |
GSM1296032 | J_lesional_day15 | 474.88 | 66 |
GSM1296024 | K_lesional_day15 | 562.19 | 70 |
GSM1296031 | W_lesional_day15 | 361.73 | 62 |
GSM1296028 | X_lesional_day15 | 545.81 | 69 |
GSM1296029 | Z_lesional_day15 | 479.28 | 67 |
GSM1296026 | F_lesional_day15 | 431.41 | 66 |
GSM1296030 | O_lesional_day15 | 262.6 | 58 |
GSM1296040 | S_lesional_day15 | 638.7 | 72 |
GSM1296036 | T_lesional_day15 | 580.6 | 70 |
GSM1296048 | V_lesional_day15 | 728.49 | 74 |
GSM1296059 | A_lesional_day43 | 593.88 | 70 |
GSM1296066 | G_lesional_day43 | 906.08 | 78 |
GSM1296060 | R_lesional_day43 | 532.05 | 68 |
GSM1296063 | U_lesional_day43 | 526.98 | 69 |
GSM1296064 | E_lesional_day43 | 701.68 | 74 |
GSM1296067 | H_lesional_day43 | 819.82 | 76 |
GSM1296062 | M_lesional_day43 | 561.67 | 69 |
GSM1296068 | Q_lesional_day43 | 1027.12 | 80 |
GSM1296050 | C_lesional_day43 | 512.56 | 68 |
GSM1296057 | D_lesional_day43 | 487.81 | 67 |
GSM1296052 | I_lesional_day43 | 320.79 | 61 |
GSM1296054 | J_lesional_day43 | 392.7 | 63 |
GSM1296049 | K_lesional_day43 | 447.84 | 66 |
GSM1296055 | W_lesional_day43 | 481.62 | 67 |
GSM1296053 | X_lesional_day43 | 630.03 | 71 |
GSM1296058 | Z_lesional_day43 | 284.85 | 58 |
GSM1296051 | F_lesional_day43 | 525.52 | 69 |
GSM1296056 | O_lesional_day43 | 391.07 | 64 |
GSM1296065 | S_lesional_day43 | 460.69 | 66 |
GSM1296061 | T_lesional_day43 | 626.2 | 71 |
GSM1296095 | A_non-lesional_pre-dose | 690.09 | 73 |
GSM1296120 | B_non-lesional_pre-dose | 808.16 | 76 |
GSM1296077 | C_non-lesional_pre-dose | 508.14 | 68 |
GSM1296093 | D_non-lesional_pre-dose | 631.32 | 71 |
GSM1296104 | E_non-lesional_pre-dose | 460.89 | 66 |
GSM1296079 | F_non-lesional_pre-dose | 541.75 | 69 |
GSM1296108 | G_non-lesional_pre-dose | 897.17 | 78 |
GSM1296110 | H_non-lesional_pre-dose | 977.37 | 79 |
GSM1296081 | I_non-lesional_pre-dose | 379.15 | 63 |
GSM1296091 | J_non-lesional_pre-dose | 344.14 | 62 |
GSM1296075 | K_non-lesional_pre-dose | 514.4 | 69 |
GSM1296112 | L_non-lesional_pre-dose | 1034.74 | 80 |
GSM1296100 | M_non-lesional_pre-dose | 508.68 | 67 |
GSM1296087 | O_non-lesional_pre-dose | 277.37 | 59 |
GSM1296118 | P_non-lesional_pre-dose | 949.85 | 79 |
GSM1296114 | Q_non-lesional_pre-dose | 1018.01 | 80 |
GSM1296097 | R_non-lesional_pre-dose | 600.94 | 71 |
GSM1296106 | S_non-lesional_pre-dose | 523.05 | 68 |
GSM1296102 | U_non-lesional_pre-dose | 797.98 | 75 |
GSM1296122 | V_non-lesional_pre-dose | 682.17 | 73 |
GSM1296089 | W_non-lesional_pre-dose | 377.04 | 62 |
GSM1296083 | X_non-lesional_pre-dose | 555.36 | 69 |
GSM1296116 | Y_non-lesional_pre-dose | 1122.46 | 82 |
GSM1296085 | Z_non-lesional_pre-dose | 446.18 | 66 |